drugset / Trial / NCT05712421
A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The North Star study is a multi-center, Phase 2, double-blind, randomized, parallel group clinical study to evaluate the safe and effective dose conversion from Levothyroxine to North Star therapy.
Timeline
- Start
- 2023-02-28
- Primary completion
- 2025-05-05
- Completion
- 2025-09-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levothyroxine | Other / unclassified | — | — |
| Subject | North Star | Unknown | — | — |